154 related articles for article (PubMed ID: 35698796)
1. A comprehensive update on the pharmacological management of heterotopic ossification following hip arthroplasty: a level I evidenced based expert opinion.
Migliorini F; Asparago G; Oliva F; Cuozzo F; Maffulli N
Expert Opin Pharmacother; 2022 Jul; 23(10):1195-1203. PubMed ID: 35698796
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
[TBL] [Abstract][Full Text] [Related]
3. Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review.
Haffer H; Müller M; Ascherl R; Perka C; Winkler T
Hip Int; 2022 Mar; 32(2):144-151. PubMed ID: 33272062
[TBL] [Abstract][Full Text] [Related]
4. Heterotopic Ossification Following Direct Anterior Total Hip Arthroplasty With and Without Postoperative Analgesic Nonsteroidal Anti-inflammatories.
Naylor BH; Iturriaga CR; Bisen YB; Caid MJ; Reinhardt KR
J Arthroplasty; 2021 Oct; 36(10):3471-3477. PubMed ID: 34130870
[TBL] [Abstract][Full Text] [Related]
5. NSAIDs for Prophylaxis for Heterotopic Ossification After Total Hip Arthroplasty: A Bayesian Network Meta-analysis.
Migliorini F; Trivellas A; Eschweiler J; Driessen A; Tingart M; Maffulli N
Calcif Tissue Int; 2021 Feb; 108(2):196-206. PubMed ID: 33044630
[TBL] [Abstract][Full Text] [Related]
6. Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey.
Barbato M; D'Angelo E; Di Loreto G; Menna A; Di Francesco A; Salini V; Zoppi U; Cavasinni L; La Floresta P; Romanò CL
J Orthop Traumatol; 2012 Jun; 13(2):63-7. PubMed ID: 22358779
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis.
Ma R; Chen GH; Zhao LJ; Zhai XC
J Orthop Surg Res; 2018 Mar; 13(1):48. PubMed ID: 29506541
[TBL] [Abstract][Full Text] [Related]
8. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.
Winkler S; Springorum HR; Vaitl T; Handel M; Barta S; Kehl V; Craiovan B; Grifka J
Int Orthop; 2016 Apr; 40(4):673-80. PubMed ID: 26728611
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analysis of naproxen for prevention heterotopic ossification after hip surgery.
Zhang AH; Chen X; Zhao QX; Wang KL
Medicine (Baltimore); 2019 Apr; 98(14):e14607. PubMed ID: 30946309
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Heterotopic Ossification Following a Multimodal Pain Protocol in Total Hip Arthroplasty With the Posterior Approach.
White PB; Ramkumar PN; Meftah M; Ghazi N; Ranawat AS; Ranawat CS
Orthopedics; 2018 Jan; 41(1):e92-e97. PubMed ID: 29120007
[TBL] [Abstract][Full Text] [Related]
11. The Effect of NSAID Prophylaxis and Operative Variables on Heterotopic Ossification After Hip Arthroscopy.
Beckmann JT; Wylie JD; Kapron AL; Hanson JA; Maak TG; Aoki SK
Am J Sports Med; 2014 Jun; 42(6):1359-64. PubMed ID: 24664136
[TBL] [Abstract][Full Text] [Related]
12. Prevention of periarticular heterotopic ossification after endoprosthetic hip joint replacement by means of diclofenac.
Jockheck M; Willms R; Volkmann R; Sell S; Weller S; Küsswetter W
Arch Orthop Trauma Surg; 1998; 117(6-7):337-40. PubMed ID: 9709846
[TBL] [Abstract][Full Text] [Related]
13. Surgical Resection Combined with Adjuvant Radiotherapy and Non-Steroidal Anti-Inflammatory Drugs in the Treatment of Heterotopic Ossification Following Total Hip Arthroplasty.
Osório T; Lemos J; Tkachuk O; Sousa R; Vasques A
Acta Med Port; 2023 Mar; 36(3):202-205. PubMed ID: 35748410
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis.
Joice M; Vasileiadis GI; Amanatullah DF
Bone Joint J; 2018 Jul; 100-B(7):915-922. PubMed ID: 29954195
[TBL] [Abstract][Full Text] [Related]
15. Chemoprophylaxis for heterotopic ossification following hip arthroscopy: A systematic review.
Dean RS; Hamama BA; Cavinatto L; Nho SJ; Chahla J; Hinckel BB
J ISAKOS; 2023 Dec; 8(6):484-489. PubMed ID: 37619960
[TBL] [Abstract][Full Text] [Related]
16. Heterotopic ossification after total hip arthroplasty.
Cohn RM; Schwarzkopf R; Jaffe F
Am J Orthop (Belle Mead NJ); 2011 Nov; 40(11):E232-5. PubMed ID: 22263220
[TBL] [Abstract][Full Text] [Related]
17. Prevention of heterotopic ossification after total hip replacement with NSAIDs.
Fijn R; Koorevaar RT; Brouwers JR
Pharm World Sci; 2003 Aug; 25(4):138-45. PubMed ID: 12964491
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib and heterotopic bone formation after total hip arthroplasty.
Lavernia CJ; Contreras JS; Villa JM; Rossi MD
J Arthroplasty; 2014 Feb; 29(2):390-2. PubMed ID: 23927909
[TBL] [Abstract][Full Text] [Related]
19. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.
Rath E; Warschawski Y; Maman E; Dolkart O; Sharfman ZT; Salai M; Amar E
Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Celecoxib Administration Is Associated With Decreased Incidence and Severity of Heterotopic Ossification After Hip Resurfacing by Direct Lateral Approach in Male Patients.
Ng M; Brigati D; Wagner TC; Bigart K; Khlopas A; Sultan AA; Mont MA; Brooks P
Orthopedics; 2018 Nov; 41(6):e807-e812. PubMed ID: 30222794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
